BAMCO Inc
DRNA

BAMCO Inc’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

BAMCO Inc’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34,762
Closed -$1.3M – 426
2021
Q2 		$1.3M Hold
34,762
– – ﹤0.01% 365
2021
Q1 		$889K Sell
34,762
-3,200
-8% -$81.7K ﹤0.01% 353
2020
Q4 		$836K Buy
37,962
+26,557
+233% +$585K ﹤0.01% 337
2020
Q3 		$205K Buy
11,405
+5,000
+78% +$104K ﹤0.01% 328
2020
Q2 		$163K Hold
6,405
– – ﹤0.01% 309
2020
Q1 		$118K Buy
6,405
+3,505
+121% +$68.1K ﹤0.01% 313
2019
Q4 		$64K Buy
+2,900
New +$58.4K ﹤0.01% 344

Other funds holding DRNA

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BAMCO Inc's DRNA Position: Q3 2021 in Review

BAMCO Inc sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 34,762 shares — an estimated $1.3M sold.

BAMCO Inc first reported a position in DRNA in Q4 2019 and held it in 7 quarters. The position peaked at $1.3M in Q2 2021. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

  • BAMCO Inc reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • BAMCO Inc sold 34,762 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.3M.
  • BAMCO Inc first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
  • BAMCO Inc's Dicerna Pharmaceuticals, Inc. position peaked at $1.3M in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on BAMCO Inc's 13F filing for Q3 2021, filed 12 Nov 2021.